Polarean_color_black.png
FDA clears XENOVIEW® 3T Chest Coil in GE HealthCare MRI Systems
21. November 2024 08:28 ET | Polarean
DURHAM, NC and LONDON, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX) (“Polarean” or the “Company”), a commercial-stage medical imaging technology leader in advanced Magnetic...
Alan Huang VP Sales
Appointment of Alan Huang, PhD, as Vice President of Sales
03. September 2024 09:02 ET | Polarean
DURHAM, NC and LONDON, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX) (“Polarean” or the “Company”), a commercial-stage medical device leader in advanced Magnetic Resonance...
Chase Hall, M.D., as Chief Medical Advisor
Appointment of Chase Hall, M.D., as Chief Medical Advisor
28. August 2024 09:01 ET | Polarean
DURHAM, NC and LONDON, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX), a commercial-stage medical device leader in advanced Magnetic Resonance Imaging ("MRI") of the lungs,...
Global Non-Cystic Fibrosis Bronchiectasis Market
$4.8 Bn Non-Cystic Fibrosis Bronchiectasis Market - Global Industry Size, Share, Trends, Opportunity and Forecasts, 2019-2029F
05. Juli 2024 10:23 ET | Research and Markets
Dublin, July 05, 2024 (GLOBE NEWSWIRE) -- The "Non-Cystic Fibrosis Bronchiectasis Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2019-2029F" report has been added to ...
Polarean_color_black.png
Polarean Raises $12.6 Million in Oversubscribed Financing Round to Accelerate XENOVIEW™ Commercialization and Strategic Growth Initiatives
20. Juni 2024 09:15 ET | Polarean
DURHAM, NC and LONDON, June 20, 2024 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX) (“Polarean” or the “Company”), a commercial-stage medical device leader in advanced Magnetic Resonance...
Polarean_color_black.png
Polarean’s Xenon MRI to be Featured at Upcoming ATS 2024 Conference
08. Mai 2024 09:02 ET | Polarean
DURHAM, NC and LONDON, May 08, 2024 (GLOBE NEWSWIRE) -- Polarean (AIM: POLX),  a commercial-stage medical device leader in advanced magnetic resonance imaging (MRI) of the lungs, has been selected...
Polarean_color_black.png
Polarean Partners with VIDA to Streamline Adoption of Advanced MRI of the Lungs
08. September 2023 08:02 ET | Polarean
Durham, NC and London, Sept. 08, 2023 (GLOBE NEWSWIRE) -- Polarean (AIM: POLX), a commercial-stage medical device leader in advanced magnetic resonance imaging (MRI) of the lungs, announced today it...
Polarean_color_black.png
CMS grants reimbursement code for the Polarean XENOVIEW™ MRI Technology
29. August 2023 08:10 ET | Polarean
Durham, NC, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Polarean (AIM: POLX), a commercial-stage medical device leader in advanced MRI scanning of the lungs, announces that the Centers for Medicare...
Avalyn-Logo-FINAL.png
Avalyn Pharma Expands Executive Team with Appointment of Howard M. Lazarus, MD, FCCP to the Role of Chief Medical Officer
07. August 2023 08:00 ET | Avalyn Pharma Inc.
Seattle, Aug. 07, 2023 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on development of targeted therapies for life-threatening pulmonary diseases, today...
Polarean_color_black.png
Polarean Receives Clearance for New MRI Chest Coil
03. August 2023 08:08 ET | Polarean
Durham, NC, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Polarean (AIM: POLX) (“Polarean” or the “Company”), a commercial-stage medical device leader in advanced MRI scanning of the lungs, announces it has...